Monday, June 22, 2026

ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing

ZEISS Medical Technology, one of the world’s leading medical technology companies, announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. Lama A. Al-Aswad, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function testing, supported by ZEISS’ long history of innovation in perimetry.

ZEISS’s collaboration with Envision Health Technologies comes at a time when demand is growing for broader access to glaucoma screenings and more flexible workflow solutions, driving enhanced industry interest in portable, software-driven approaches to visual function testing. Through this strategic collaboration, ZEISS and Envision Health Technologies will bring together clinical expertise and software innovation to help advance clinically relevant, patient-centered technologies for modern glaucoma care.

“As glaucoma care continues to evolve, clinicians are looking for solutions that improve patient accessibility, flexibility and experience without compromising clinical confidence. Our collaboration with Envision Health Technologies reflects ZEISS’ commitment to advancing practical, clinician-driven innovation that can help expand access to visual function testing across a range of care settings,” says Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology.

Also Read: What Is Warehouse Automation and How Is AI Transforming Modern Fulfillment Centers in 2026?

“We believe the future of visual function testing should be more accessible, flexible, and patient-centered while remaining grounded in clinical rigor. Collaborating with ZEISS allows us to combine cutting-edge software innovation with decades of trusted market leadership in perimetry to help advance more practical solutions for real-world glaucoma care,” says Lama A. Al-Aswad, MD, MPH, Founder and CEO of Envision Health Technologies. As a leading glaucoma surgeon, Dr. Al-Aswad founded Envision Health Technologies to improve outcomes for vision-threatening diseases, developing next-generation, data-driven solutions to transform how vision care is delivered, measured, and scaled.

SOURCE: ZEISS

Subscribe Now

    Hot Topics